
Evolocumab was associated with a 20% lower risk of fatal or nonfatal myocardial infarction than ezetimibe among more than 544 000 adults with ASCVD.
Pt video: Woke with symptoms. PMH: hypertension, arrhythmias. PPD smoker, drinks ETOH. More history, here.
A 58 y/o man describes waking in the morning with a severely swollen face. He had been fine the night before. Dispatch info: HTN (BP: 190/99); dizzy, abdominal guarding. Hx of dyspnea, arrhythmias. Denies allergies, chemical exposure. PPD smoker, heavy ETOH. Watch the full interview.






